Rising Biosciences Inc RBII

Rising Biosciences Inc is a United States-based company engaged in the research and development activities. It is focused on the oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.